Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC

Background Cancer-associated fibroblasts (CAFs) significantly impact cancer progression and CAF subtypes are key determinants of response to immune checkpoint therapy (ICT). The transforming growth factor-β (TGF-β) signaling is a main pathway in protumorigenic activity of CAFs and resistance to ICT....

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Paola Nisticò, Isabella Sperduti, Paolo Visca, Lorenzo D’Ambrosio, Francesca Paolini, Annalisa Tocci, Belinda Palermo, Anna Di Carlo, Francesca Di Modugno, Filippo Gallina, Roberta Melchionna, Giulia Campo, Riccardo Tajè, Daniel D’Andrea
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 2026-01-01
Saila:	Journal for ImmunoTherapy of Cancer
Sarrera elektronikoa:	https://jitc.bmj.com/content/14/1/e013098.full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!